BioSpace News Archive

VAXIL BIO LTD., an innovative immunotherapy biotech company specializing in cancer and infectious diseases, is pleased to provide further update to the Company’s press release dated February 13, 2020 on the possible identification of a corona virus vaccine candidate.

BURLINGTON, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the 9 th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at the Lotte New York Palace Hotel in New York City. The Company is scheduled to present at 10:00 a.m. EST. About LeMaitre Vascular LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a

VisiQuate Inc. announced that the University of Chicago Medicine has finalized a multi-year agreement with VisiQuate to deploy advanced analytics.

Avantor, Inc. announced that Michael Stubblefield, President and Chief Executive Officer, will participate in Cowen and Company’s 40th Annual Health Care Conference at the Boston Marriott Copley Place Hotel in Boston, Massachusetts.

API, an Italian company specialized in the production of thermoplastic elastomeric compounds and bioplastics which was acquired by global materials company Trinseo in July 2017, will be presenting the new expandable bio-based TPU APILONTM 52 BIO LIGHT at SIMAC Tanning Tech 2020, February 19-21, in Milan, Italy – Hall 14, Booth C48.

Opthea Limited announced that Dr Megan Baldwin, CEO of Opthea, will present and provide a corporate update at the 9th Annual SVB Leerink Global Healthcare Conference on February 25, 2020 at 11am EST in New York City.

NanoString Technologies, Inc., a leading provider of life science tools for translational research, announced that the company’s management is scheduled to present at the 40th Annual Cowen Healthcare Conference in Boston.

LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has initiated further studies with the University of Wisconsin-Milwaukee to establish the use of their Photobiomodulation platform in Diabetic Retinopathy (DR).

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), today announced the appointment of Nina Ohara, PharmD, M.B.A., as Director, Marketing, reporting to Deanne Melloy, Aerie’s Vice President of Marketing.

Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, today announced that management will host a conference call and webcast to discuss its fourth quarter and full year 2019 financial results and present at upcoming investor conferences